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Siderophores are low-molecular-weight iron chelators that are produced and exported by 
bacteria and fungi during periods of nutrient deprivation. The structures, biosynthetic logic, and 
coordination chemistry of these molecules have fascinated chemists for decades. Studies of 
such fundamental phenomena guide the use of siderophores and siderophore conjugates in a 
variety of medicinal applications that include iron-chelation therapies and drug delivery. Sensing 
applications constitute another important facet of siderophore-based technologies. The high 
affinities of siderophores for both ferric ions and siderophore receptors, proteins expressed on 
the cell surface that are required for ferric siderophore import, indicate that these small 
molecules may be employed for the selective capture of metal ions, proteins, and live bacteria. 
This minireview summaries progress in methods that utilize native bacterial siderophore 
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I. Introduction 
Iron is an essential nutrient for most organisms.1-3 This first-row transition metal ion is 
involved in multiple biological phenomena essential to life that include oxygen transport and 
respiration, electron transfer, DNA synthesis and repair, and primary metabolism. Iron-
containing enzymes also participate in secondary metabolism and the oxidative stress 
response. Iron is typically found in the +2 (ferrous) and +3 (ferric) oxidation states in biological 
systems, and higher oxidation states are achieved transiently during enzymatic catalysis. 
Organisms acquire this important nutrient by employing dedicated mechanisms for iron 
acquisition, transport, and storage.2,4,5 Prokaryotes require micromolar (10-6 M) concentrations 
of iron to replicate and colonize, and are thus faced with a metabolic predicament because the 
concentration of Fe(III) at neutral pH is low (ca. 10-18 M).6 Moreover, the free iron concentrations 
in living organisms, including the vertebrate host, are strictly regulated at lower concentrations 
(ca. 10-24 M in human serum)6 because of the inherent toxicity of the metal ion, which results 
from its propensity cycle between the Fe3+/Fe2+ oxidation states and generate deleterious 
radicals via Fenton chemistry. To acquire the concentrations of iron necessary to thrive in 
nutrient-limited environments, prokaryotes utilize a variety of strategies for iron acquisition.2 
Both Gram-negative and –positive bacteria produce and export siderophores (Figure 1),7-9 a 
family of low-molecular-weight iron chelators, which are a focus of this minireview. Other tactics 
for iron acquisition include the uptake and utilization of heme iron,10,11 which has been observed 
for Staphylococcus aureus, Escherichia coli, and Mycobacterium tuberculosis, and the 
expression of transferrin receptors on the cell surface, which allows various pathogenic species 
such as Neisseriaceae and Pasteurellacea, to obtain iron from host transferrin.12,13 Acquisition 
of iron by these three mechanisms is associated with virulence.9,11-16 
Siderophores comprise a family of low-molecular-weight iron chelators that are produced 
and exported by bacteria, fungi and plants, during periods of nutrient deprivation.7,8 Most 
siderophores exhibit extraordinarily high affinity and selectivity for iron(III) with binding constants 
(Ka) ranging from 1030 M-1 to 1052 M-1 (Table 1).17,18 Since mycobactin P was first isolated in 
1949,19 over 500 siderophores have been discovered, and approximately one half of these 
molecules have been characterized structurally.7 Figure 1 presents siderophores 1-11, which 
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highlight the structural diversity of this iron chelator family. Table 1 summarizes the producer 
organisms and iron affinities of select siderophores. With few exceptions (i.e. pyochelin 2, vide 
infra), siderophores provide hexadentate coordination spheres for Fe(III) complexation and 
coordinate this metal ion with 1:1 stoichiometry. Figure 2 depicts ferrioxamine B,20 Fe(III)-
coordinated ferrichrome21 and yersiniabactin,22 and the vanadium(IV) complex of enterobactin.23 
Catecholates, hydroxamates, and α-hydroxycarboxylates are common bidentate ligands utilized 
by siderophores. Enterobactin is a canonical example of a triscatecholate scaffold whereas 
desferrioxamine and petrobactin are hydroxamate- and α-hydroxycarboxylate-utilizing 
siderophores, respectively. Heterocycles, formed via the enzyme-catalyzed cyclization of Ser 
and Cys building blocks,24 provide basic nitrogen atoms and hence another strategy for iron 
coordination by siderophores as exemplified by pyochelin 2 and yersiniabactin 4.  
Nonribosomal peptide synthetase (NRPS) assembly lines are responsible for the 
biosynthesis of many siderophores.8,24,25 The logic of these macromolecular machines has been 
covered elsewhere, and we direct the reader to comprehensive reviews on this topic for further 
information.26,27 Siderophores are actively transported to the extracellular environment by 
dedicated export machinery. Following extracellular iron sequestration, the resulting ferric-
siderophore complexes are captured by specific membrane receptors (Kd values are typically in 
the nanomolar range), providing a means for iron uptake.28-30 The structures and mechanisms of 
siderophore uptake machinery vary for Gram-negative and –positive bacteria. Gram-negative 
bacteria have a double-layer membrane structure,31 and utilize an outer membrane receptor, a 
periplasmic binding protein, an inner membrane ABC transporter, and the TonB complex for 
ferric siderophore transport. The TonB complex controls the transfer of the siderophore from the 
outer membrane receptor to the periplasm binding protein, and the ABC transporter provides 
cytoplasmic entry.32,33 Less is known about the siderophore uptake process in Gram-positive 
bacteria; these species express lipoproteins and ABC transporters that may be responsible for 
ferric-siderophore transport.2,34 Both the biosynthesis and transport of siderophores are 
regulated by repressor proteins that are sensitive to iron concentration. For example, Fur is the 
iron-uptake regulation protein expressed by most Gram-negative bacteria. Fur is a Fe(II)-binding 
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protein, and the holo form coordinates to specific DNA regulatory sequences, thereby 
repressing the transcription of relevant genes when iron levels are high.35,36  
Comprising a family of important natural products with fascinating structural features, 
total syntheses of many siderophores have been achieved, providing entry points into 
modification of these intriguing scaffolds for various applications. One established medicinal use 
of siderophores and synthetic siderophore mimics is in the treatment of iron-overload diseases 
including hemochromatosis and thalassemia.37,38 Desferrioxamine B is an FDA-approved iron 
chelator for the treatment of such diseases. Along these lines, siderophores and siderophore 
mimics also have potential as cancer therapeutics because cancer cells require high 
concentrations of iron for proliferation.39,40 Starving cancer cells of iron using siderophore-based 
compounds is therefore of interest for cancer therapy. Another active research area is the 
design and application of siderophore-drug conjugates.41 This work is largely inspired by a 
family of naturally-occurring siderophore-antibiotic conjugates called sideromycins, which 
includes the Streptomyces natural product albomycin.42,43 These remarkable secondary 
metabolites serve as “Trojan horse” antibiotics that are recognized and transported into recipient 
bacterial cells by siderophore uptake machinery. Applying the same strategy, a range of 
synthetic siderophore-antibiotic conjugates have been designed, synthesized, and evaluated for 
antibacterial activity.44-47 These conjugates generally exhibit β-lactams, fluoroquinolones, 
sulfonamides, and other small-molecule drugs coupled to hydroxamate- and catechol-based 
siderophores or siderophore-inspired molecules. A mycobactin-artemisinin conjugate was 
reported recently and exhibits activity against Mycobacterium tuberculosis and the malaria 
pathogen.48 
From the standpoints of therapeutic and analytical potential, siderophores hold 
significant promise. With a focus on the latter arena, the following sections of this minireview 
summarize siderophore-based strategies for Fe(III) sensing and pathogen detection. In both 
cases, the exquisite specificity and high affinity of a siderophore for ferric ion or its receptor 
provide the basis for using these molecules as sensors or probes. In Section II, we review 
siderophore-based iron detection with focus on fluorescent molecules. This sensing sub-
discipline is established, but has received less critical review than other areas of fluorescence-
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based metal-ion sensing.49-51 Fluorescence probes incorporating siderophore scaffolds that 
provide rapid, selective and sensitive responses to Fe(III) hold significant promise for 
investigating iron uptake by siderophore-utilizing organisms and, more broadly, the roles of iron 
in biology with particular emphasis on the so-called labile iron pool.52,53 These tools are also 
useful for monitoring iron concentrations in environmental and clinical samples. In Section III, 
we cover developing technologies that provide siderophore-based pathogen capture.54-56 These 
proof-of-concept studies are motivated by a need for rapid and reliable methods for detecting 
virulent bacteria in food products, the environment, and in clinical samples. We intend for this 
review to complement prior reviews that address siderophore coordination chemistry,18,57 
siderophore-based chelation therapy,37,38 siderophores and cancer therapy,39,40,58 and 
siderophore-antibiotic conjugates for drug delivery.41,44-47,58 We chose to limit the scope of this 
minireview to platforms that utilize native siderophore scaffolds rather than siderophore mimics. 
A wealth of literature pertaining to the design, synthesis, and application of siderophore analogs 
exists,59-72 some of which has been reviewed recently,18 and we note that a number of these 
molecules are fluorescent Fe(III) sensors.65-72 
 
II. Strategies for Fe(III) Detection 
 In this section, we highlight select examples where naturally-occurring siderophores 
have been employed for the detection of Fe(III) by using fluorescence. We first consider 
naturally-emissive siderophores, including pyoverdines (i.e. 1) produced by Pseudomonas spp. 
and azotobactin 3 from the soil bacterium Azotobacter vinelandii.9,73-83 Next, we evaluate several 
synthetic fluorophore-siderophore conjugates where fluorophores are attached to native 
siderophore scaffolds to provide fluorescence responses following Fe(III) coordination.84-88 Iron 
is a paramagnetic metal ion and thus has a propensity to quench fluorophore emission. As a 
result, most of the siderophores described herein afford fluorescence quenching or “turn-off” 
following Fe(III) recognition. Lastly, we present a lanthanide-based approach where Fe(III) 
coordination results in lanthanide displacement and loss of lanthanide luminescence.89  
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II.a. Fe(III) Detection Based on Naturally-Emissive Siderophores 
 Among the most celebrated fluorescent siderophores are the pyoverdines (i.e. 1),90 
which are produced by all fluorescent pseudomonads including Pseudomonas aeruginosa and 
P. fluorescens, and the nitrogen-fixing soil bacterium Azotobacter vinelandii. The PVD gene 
cluster of Pseudomonas spp. is responsible for the biosynthesis of pyoverdines.91 These 
nonribosomal peptides are comprised of a N-terminal dihydroxyquinoline chromophore, a 
peptide arm of six to twelve residues in length, and a side chain that is most often a small 
dicarboxylic acid or amide (Figure 1).90 The length and composition of the peptide arm are 
highly variable and strain-specific. Both L- and D-amino acids, in addition to a number of unusual 
monomeric building blocks such as hydroxaspartate and Nδ-hydroxyornithine, comprise the 
peptide arms. Over fifty pyoverdines or pyoverdine-like natural products have been isolated and 
structurally characterized.92 Pyoverdines form hexacoordinate Fe(III) complexes (Ka ~ 1029 M-1) 
and bind iron by using both hydroxamate and catecholate groups. Other emissive siderophores 
include azotobactins (i.e. 3),93,94 pyochelin 2,95 and scaffolds containing spermidine (i.e. 
parabactin, 8) or other groups that emit light, albeit weakly. In this section, we describe 
examples where a naturally-occurring siderophore has been employed for Fe(III) detection. In 
all cases, the siderophores were isolated and purified from cultures of the producing organism 
and iron coordination results in quenching or “turn-off” of siderophore emission. We first 
consider fluorescent siderophores employed for Fe(III) sensing in solution.73-75 Subsequently, 
we describe efforts to immobilize siderophores in materials, including micelle-templated silica 
and sol gel, for the optical detection of this metal ion.76-81,83  
 Azotobactin δ 3 is a fluorescent siderophore produced by Azotobacter vinelandii and 
shares structural similarities with the pyoverdines. In the laboratory, this natural product can be 
isolated in quantities of 100 – 200 mg/L of culture when a mutant strain that overproduces the 
siderophore is employed,96,97 providing sufficient quantities for extensive analytical work. 
Azotobactin δ is comprised of a decapeptide, (L)-Asp-(D)-Ser-(L)-Hse-Gly-(D)-β-threo-HOAsp-
(L)-Ser-(D)-Cit-(L)-Hse-(D)-Nδ-Acetyl, Nδ-HOOrn-(L)-Hse lactone, appended with an N-terminal 
6,7-diamino-2,3-dihydroxyquinoline chromophore (Figure 1; Hse, homoserine; HOAsp, 
hydroxyaspartic acid; Cit, citrulline; HOOrn, hydroxyornithine). Azotobactin δ utilizes the 
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hydroxamate group of Nδ-Acetyl, Nδ-HOOrn, the α-hydroycarboxylic moiety of β-threo-HOAsp, 
and the dihydroxyquinoline-derived catechol group to coordinate Fe(III).74 The optical absorption 
spectrum of azotobactin δ in aqueous solution at pH 5 exhibits a maximum at 380 nm (ε = 
23,500 M-1cm-1-) and a shoulder at 336 nm (ε = 19,600 M-1cm-1). Addition of Fe(III) to solutions 
of azotobactin δ results in a red-shift in the wavelength of maximum absorption to 412 nm (ε = 
23,000 M-1cm-1) with shoulders at 450 (ε = 10,000 M-1cm-1) and 550 nm (ε = 2,000 M-1cm-1). The 
shoulders are attributed to LMCT originating from the dihydroxyquinoline-based catecholate and 
hydroxamate binding sites. The stability constant for the ferric azotobactin δ complex was first 
reported to be ca. 1030 M-1 from thermodynamic analysis,73 and subsequent kinetic analyses 
and potentiometry from the same research group provided a value of 1.9 x 10-10 M-5.74 
 Azotobactin δ provides maximum emission at 490 nm (λex = 380 nm) in acetate buffer 
(pH 4.4). Addition of one equivalent of Fe(III) to solutions of azotobactin δ causes fluorescence 
turn-off and a slight blue-shift in the wavelength of maximum absorption.73 The quantum yield 
for azotobactin is 0.28 at pH 2 (6-hydroxypyrene-1,3,6-trisulfonic acid standard; Φ = 0.96, pH 
2).97 A fluorescence assay for Fe(III) determination using azotobactin δ provided a linear range 
between 0 – 95 ng/mL Fe(III) and a detection limit of 0.5 ng/mL (89 nM; acetate buffer, pH 
4.4).73 The emission readout from this assay was not perturbed by Na(I), Ca(II) or Mg(II) (2 to 5 
x 103-fold higher concentrations than that of ferric ion) whereas low concentrations of Cu(II) and 
Al(III) compromised the Fe(III)-induced response. 
A fluorescence method employing azotobactin as an Fe(III) reporter was subsequently 
devised for quantifying non-transferrin-bound iron (NTBFe) in the serum of thalassemia 
patients.75 Thalassemics suffer from iron overload and concentrations of NTBFe can reach 10 
µM in the serum of these patients. This disease is prevalent in developing countries, motivating 
the development of facile and inexpensive detection methods for monitoring NTBFe levels. This 
azotobactin-based approach involves (i) saturation of any apo transferrin in the serum by Co(III) 
addition, (ii) mobilization of non-transferrin-bound iron by using nitrilotriacetic acid, (iii) removal 
of all serum proteins, and (iv) addition of azotobactin to the resulting solution to quantify Fe(III) 
by using a calibration curve prepared with iron-spiked serum from healthy human subjects. 
Samples from sixty-three thalassemics were analyzed by this assay, which provided Fe(III) 
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concentrations in the range of 0.07 – 3.24 µM. These values correlated with serum iron levels 
and percent transferrin saturation, and also with colorimetric determination of Fe using the 
established bathophenanthrolinedisulfonate (BPT) method. It should be noted that fluorescence-
based assays for NTBFe using synthetic siderophore-fluorophore conjugates98 and fluorophore-
modified iron-binding proteins99 have been reported and reviewed elsewhere.52 In general, 
fluorescence-based techniques have the advantages that iron concentrations can be monitored 
rapidly on-site and without the need for sophisticated instrumentation (i.e. inductively coupled 
plasma mass spectrometry or atomic absorption spectroscopy); however, one drawback is that 
serum/sample color and also sample turbidity are oftentimes variable and may interfere with the 
fluorescence measurements. 
Fluorescent siderophores also find application in assays designed for either monitoring 
Fe(III) levels in water samples, and in technologies for waste water treatment. The tactics 
highlighted below all involve the encapsulation or immobilization of a fluorescent siderophore 
into a material, which thereby sequesters iron from the aqueous phase. In many instances, 
these materials are incorporated into flow cells and afford rapid quantification of Fe(III), and are 
recyclable. Such portable Fe(III) detectors are amenable for work in the field, which includes the 
rapid analysis of environmental samples and potentially quick clinical diagnostics. Most of the 
examples described below utilize pyoverdine (i.e. 1). Pyoverdine exhibits high water solubility, 
forms a 1:1 complex with Fe(III),100 and exhibits maximum emission at ca. 450 nm in solution. 
Like azotobactin δ, pyoverdine affords a turn-off fluorescence response to Fe(III). Pyoverdine 
has been immobilized on controlled pore class (CPG), in large-pore micelle-templated silica 
(MTS), and in sol gels for Fe(III) detection.76-79  
In the early 1990s, pyoverdine was immobilized on CPG and thereby incorporated into a 
flow cell, which provided iron determination in the 10 – 200 ng/mL range and a modest detection 
limit of 3 ng/mL.76 This approach was employed to evaluate iron concentrations in tap and 
mineral waters, and the resulting data were in agreement with data obtained by inductively 
coupled plasma atomic emission spectroscopy (95% confidence level). Because acidification 
results in catechol protonation and release of Fe(III) from pyoverdine, the flow cell was 
regenerated by flushing with 1 M HCl, and longevity studies revealed that an individual cell had 
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a lifetime of ca. three months or one-thousand measurements. Subsequently, this method was 
modified to for the analysis of iron speciation by outfitting the flow cell with a column containing 
persulfate.77 When the column was bypassed, the flow cell only reported on Fe(III). Flowing the 
solution of interest through the persulfate column resulted in oxidation of any Fe(II) to Fe(III) and 
thereby provided a measurement of total dissolved iron. This particular system was employed to 
determine total iron levels in tap water, well water, and wine. Like the first-generation sensor, 
this system was used repeatedly over the course of three months. Ten to fifteen samples may 
be processed each hour.  
A related tactic is to encapsulate or immobilize pyoverdine in MTS.78,79 A direct synthetic 
procedure was first devised where pyoverdine was dissolved in the templating micelles, and the 
resulting MTS provided reversible fluorescence quenching with Fe(III) addition.78 This 
preparation, however, resulted in insufficient encapsulation of the pyoverdine and alternative 
immobilization strategies were subsequently pursued. Along these lines, pyoverdine was 
covalently attached to a glycidoxy-grated large-pore MTS and a commercial high-grade 
glycidoxy-grafted silica gel (Figure 3).79 These materials served as metal ion sponges and 
sequestered iron from solutions containing mixed metal samples. In some instances, chromium 
interference was observed. Pyoverdine was also entrapped in sol-gel glass for Fe(III) 
detection.81,83 In one case, the siderophore exhibited maximum emission at 405 nm when 
encapsulated in the sol-gel, and maximum intensity was observed in the pH 5 to 7.5 range. 81 
Pyoverdine retained its Fe(III)-induced turn-off fluorescence response in the sol gel, and these 
Fe(III)-responsive materials exhibited greater stability than the CPG-based systems described 
above. The detector was employed to analyze iron concentrations in Madrid tap water and 
human serum.81 
Lastly, the intrinsic emission of parabactin (8, Figure 1) has been employed for the 
detection of bioavailable Fe(III) in ocean waters.82 Parabactin is a spermidine catecholate 
siderophore produced by Paracoccus denitrificans that employs two catechol moieties and a 2-
(2-hydroyxl)oxazoline to form a wine-colored hexacoordinate iron complex with a Ka value of 
1048 M-1 at basic pH.101 In ethanol and in aqueous solution adjusted to pH 3.1, parabactin 
exhibits three absorption bands centered at 210, 250 and 311 nm. The latter two absorption 
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bands red shift to 253 and 316 nm at pH 8. Addition of Fe(III) to solutions of parabactin results 
in a new absorption feature centered at 500 nm (10 mM tricine buffer, pH 8). The emission 
spectrum of apo parabactin also exhibits solvent- and pH-dependence; the wavelength of 
maximum emission is observed at 401 (ethanol), 440 (pH 3.3) or 460 nm (pH 8.0) following 
excitation at 311 nm. Addition of Fe(III) to solutions of parabactin results in fluorescence 
quenching. To provide a recyclable biosensor for Fe(III) determination in ocean waters, 
parabactin was added to a sol-gel solution and the mixture was spin coated onto quartz.82 The 
encapsulated parabactin exhibited absorption and emission properties similar to those observed 
for free parabactin at pH 3.1, which was attributed to an acidic microenvironment in the pores 
resulting from the acid-catalyzed preparation of the sol gel. A flow cell was outfitted with the sol 
gel, and parabactin emission turned off when aqueous Fe(III) was flushed through the devise. 
Using this Fe(III)-dependent fluorescence change, an Fe(III) calibration curve was prepared 
(0.05 to 1 nM) and a detection limit of 40 pM for Fe(III) achieved, the latter of which is 
impressive given that the emission from parabactin is not especially bright as judged by the 
chromophore (Φ and ε values were not reported in this work). To further evaluate this strategy, 
the Fe(III) content in a standard seawater reference sample was determined to be 3.24 ± 0.35 
nM, in good agreement with the certified value of 3.71 ± 0.63 nM. Next, seawater samples 
collected from varying depths (3 to 303 m) in the North Atlantic Ocean (49o38.0’N, 18o31.8W) 
were analyzed, and the parabactin-derived biosensor reported that iron concentrations vary 
from <100 pM in surface waters to 700-1000 pM at a depth of 300 m. This concentration range 
is similar to those reported by others studying iron concentration gradients in the North Atlantic 
Ocean.102 
 
II.b. Fe(III) Detection Based on Synthetic Fluorophore-Siderophore Conjugates 
 A complementary approach to siderophore-based optical detection of Fe(III) is to modify 
naturally-occurring siderophores with synthetic fluorophores, affording siderophore-fluorophore 
conjugates that provide changes in emission following Fe(III) coordination. This tactic requires 
that the siderophore has a functional group amenable to synthetic modification, and that 
fluorophore conjugation has negligible impact the iron-binding properties of the chelate. To date, 
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the DFO and pyochelin scaffolds have been utilized for the assembly of Fe(III)-responsive 
siderophore-fluorophore conjugates (Figures 4-6).53,84-86,88,103 The DFO conjugates 12-16 
(Figures 4 and 5) provide turn-off sensing of Fe(III) whereas fluorescence enhancement or 
“turn-on” detection of this metal ion is achieved with the pyochelin conjugates 17-18 (Figure 6). 
Advantages of employing DFO include its commercial availability and its N-terminal amino 
group, the latter of which is a synthetic handle for fluorophore attachment. Preparation of the 
pyochelin-fluorophore conjugates required multistep syntheses, and these routes provide 
access to a multitude of other pyochelin-based molecules.104  
 
II.b.i. DFO-Fluorophore Conjugates for Turn-Off Fe(III) Detection  
DFO, 5, is a hydroxamate-based siderophore produced by the soil actinomycete 
Streptomyces (Figure 1). Although it is the first and only FDA-approved siderophore drug for 
treating iron-overload disease, the lack of oral availability and low cell permeability limit its utility. 
In the early 1990s, a derivative of DFO bearing a terminal nitrobenz-2-oxa-1,3-diazole (NBD) 
moiety was reported (12, NBD-DFO, Figure 4).84 NBD-DFO is water-soluble, exhibits maximum 
emission centered at 548 nm (λex = 475 nm), and affords fluorescence quenching upon addition 
of Fe(III) (10 mM HEPES, 100 mM NaCl, pH 7.4). Mixtures of acid (pH < 5) and excess EDTA 
reverse Fe(III)-induced turn-off, confirming that NBD-DFO is a turn-off Fe(III) sensor and that 
the fluorophore-modified chelate retains a high-affinity for this metal ion. A stability constant for 
NBD-DFO for Fe(III) was not reported and is assumed to be similar to that of parent DFO (Table 
1). Negligible changes in apo NBD-DFO emission occur following addition of Ca(II) and Mg(II) 
whereas Mn(II), Zn(II) and Cu(II) afford variable degrees of fluorescence quenching. The turn-off 
behavior induced by Mn(II) and Zn(II) is only observed with excess metal ion (100 to 200-fold 
greater than ferric ion). In contrast, introduction of one equivalent of Cu(II) into solutions of NBD-
DFO results in quenching. The copper-induced fluorescence decrease is reversible by addition 
of acid, suggesting a means of differentiating a turn-off response generated by Cu(II) or Fe(III) 
by using acid and acid/EDTA mixtures.  
 NBD-DFO was subsequently employed in two biological contexts.84,85 In one report, the 
anti-plasmodium activity of NBD-DFO was evaluated.84 DFO itself suppresses malarial infection 
	   12 
in vitro and in several rodent/primate species in vivo, but exhibits slow penetration into 
erythrocytes, which hinders its therapeutic utility. NBD is relatively lipophilic and NBD-DFO lacks 
the terminal amino group of the parent compound, suggesting that this fluorophore modification 
may result in improved cellular uptake and more potent inhibition of P. falciparum growth. The 
ability of NBD-DFO to inhibit intraerthyrocytic P. falciparum growth was therefore investigated.  
Dose-response studies revealed an IC50 value of 5 +/- 0.62 µM. This value is 5-to-6-fold lower 
than the IC50 value of unmodified DFO (26 +/- 5 µM). Apo NBD-DFO uptake experiments 
employing uninfected and infected erythrocytes monitored by NBD emission suggested that the 
uptake was highly selective for the infected cells. Complementary uptake studies employing 
radiolabeled 59Fe-NBD-DFO revealed that the negligible cellular entry of iron-bound form. 
 NBD-DFO was subsequently utilized to monitor iron uptake in maize and cotton roots.85 
Radiolabeled 55Fe-NBD-DFO was transported into both maize and cotton roots that were 
cultured in iron-deficient media. A time-dependent fluorescence increase in both the cotton and 
maize roots treated with Fe-bound NBD-DFO was observed over ca. fifteen hours by 
fluorescence microscopy. The magnitude of fluorescence enhancement was greater for roots 
that were cultured in iron-deficient media compared to those supplemented with 100 µM 
FeEDTA. Because NBD-DFO binds Fe(III) reversibly, one possible explanation for the observed 
fluorescence enhancement is iron release from NBD-DFO and hence the monitoring of 
intracellular siderophore dynamics and iron utilization. Other explanations include (i) uptake of 
ferric NBD-DFO because the observed fluorescence increase results from weak emission from 
this coordination complex and (ii) instability of the probe manifest as photoactivation.  
Fluorescein-derivatized DFO conjugates (13, FL-DFOthio; 14, FL-DFOam, Figure 4) have 
also been reported.52,53,86,87 These particular siderophore-fluorophore conjugates are appealing 
from the photophysical perspective because fluorescein exhibits high brightness (Φ x ε) and 
water compatibility.105 Compounds 13 and 14 each exhibit a fluorescein moiety coupled to the 
N-terminal amine of the siderophore, provide turn-off Fe(III) sensing in aqueous solution, and 
are biologically compatible. Sensor 13 was once commercially available from Molecular Probes, 
Inc. (now Invitrogen) and has been employed to measure levels non-transferrin-bound iron in 
serum.98,99 One assay measured desferrioxamine-chelatable iron (DCI) in serum, which can be 
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used as an efficiency index of a chelation therapy. Patients treated with deferiprone, an iron-
chelating drug, showed substantial increase of DCI after two hours of oral administration. 
Deferiprone has much better cell permeability than DFO. The results of this study indicated that 
deferiprone shuttles intracellular iron to extracellular DFO, suggesting a new chelation therapy 
by using a combination of deferiprone and DFO. In another recent application, FL-DFOam 14 
was immobilized onto mesoporous silica to provide highly selective and sensitive iron 
nanosensors.86 The optimized sensor, which exhibited minimal FL-DFOam leaching, was 
prepared by covalently anchoring FL-DFOam to the amine-functionalized internal surface of the 
mesoporous silica material. This hybrid material can be compressed into small pellets, which 
exhibit a linear response to Fe(III) concentrations in the low-micromolar range when incubated 
in solutions containing this metal ion. Selectivity studies showed that Ca(II), Al(III), and Ni(II) do 
not interfere with the response, and Cu(II) partially quenches the sensor emission. Further 
development of this approach may provide portable and stable iron nanosensors with high 
sensitivity and selectivity for use in the field.  
The last examples of fluorophore-DFO conjugates that provide fluorescence quenching 
with Fe(III) coordination are 15 and 16, the former of which was designed for tumor imaging and 
treatment (Figure 5).87 Multifunctional conjugate 15 is comprised of a near-infrared (NIR) 
fluorescent moiety (cypate), a cyclic peptide (RGD) for receptor-specific recognizing and cellular 
internalization, and the DFO moiety. The RGD peptide binds the integrin αVβ3 receptor (ABIR). 
This receptor is overexpressed on the endothelial cells in many tumors and therefore is a target 
for tumor imaging, diagnosis, and therapy. An in vitro study using ABIR-positive cells revealed 
that incorporation of RGD peptide improved the cellular uptake of DFO, and the conjugate 
remained in the cellular space for up to 10 h. Cellular distribution studies showed that 
compound 15 accumulated in the mitochondria, lysosomes and the cytosol. Further studies 
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II.b.ii. Pyochelin-Fluorophore Conjugates for Turn-On Fe(III) Detection  
 Pyochelin (2, Figure 1) is a yellow-green emissive siderophore that was first isolated 
from Pseudomonas aeruginosa cultures in the late 1970s.106,107 In contrast to the siderophores 
discussed thus far, pyochelin contains neither catecholate nor hydroxamate groups. It is a 
tetradentate ligand that coordinates Fe(III) via one phenolate and one carboxylate oxygen atom, 
and two nitrogen atoms from thiazoline and thiazolidine heterocycles. Pyochelin forms 1:1 and 
1:2 Fe:L complexes, with the second pyochelin proposed to coordinate in a bidentate fashion, 
and exhibits relatively low Fe(III) affinity compared to other siderophores (Table 1).106,108 
Pyochelin also forms coordination complexes with Co(II), Ni(II), Cu(II), and Zn(II) and Mo(VI).109 
Because of its unusual structure, relatively weak Fe(III) affinity, and the relatively low levels of 
pyochelin produced by Pseudomonas cultures, this natural product has been described by 
some as a “secondary siderophore.”90  
 Two pyochelin-NBD conjugates, 17 and 18, that provide fluorescence enhancement 
following Fe(III) coordination in aqueous solution were reported recently (Figure 6).88 These 
sensors differ from one another in the nature of the linker installed between the siderophore and 
fluorophore moieties. Sensor 17 exhibits a relatively short succinate linker whereas a long and 
flexible polyethyleneglycol moiety is incorporated into 18. In both molecules, the linker is 
connected to pyochelin via the N3” position, which is involved in iron coordination. The 
syntheses of 17 and 18 involved eleven and twelve steps, respectively, and both molecules 
retained iron-coordinating ability. Addition of Fe(III) to aqueous solutions of 17/18 resulted in 
fluorescence enhancement centered at 545 nm (150 mM Tris buffer, pH 8).  Five equivalents of 
Fe(III) were required for maximum turn-on with 2.9- and 3.2-fold emission enhancement 
observed for 17 and 18, respectively. This turn-on behavior is in striking contrast to the 
fluorescence quenching observed for unmodified pyochelin following Fe(III) coordination.95,106 
Job plot analyses indicated 1:2 and 1:3 Fe:L stoichiometries for 17 and 18, respectively. Neither 
selectivity of 17/18 for Fe(III) over other first-row transition metal ions nor whether the 
fluorescence turn-on is specific for Fe(III) were reported, and future studies along these lines 
are warranted. Fluorescence microscopy studies employing P. aeruginosa PAD07, a strain 
expressing the pyochelin receptor FptA, indicated that FptA binds and transports 17. 
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Intracellular fluorescence from the NBD chromophore was observed. In contrast, no cellular 
labeling was observed for P. aeruginosa DH51, which does not express FptA, following 
incubation with 17. These preliminary experiments indicate that 17 is suited for studying 
pyochelin uptake in Pseudomonas and other organisms, and that FptA may transport various 
pyochelin-derivatized cargos.  
 To date, few turn-on fluorescent detectors for Fe(III) have been reported,49,72,110-112 
making these pyochelin-fluorophore conjugates important contributions to the broad field of 
metal-ion sensing. Moreover, several of the turn-on Fe(III) sensors reported to date have 
relatively low affinity (Kd ~ 5 – 300 µM) and hence high detection limits, which limit practical 
utility.49 Unraveling the photophysical properties of the apo and iron-bound forms of 17/18, and 
precisely how the synthetic modifications at the N3” position influence the coordination behavior 
of pyochelin, will be enlightening and provide insight for the design of second-generation turn-on 
pyochelin-based metal-ion sensors in addition to other types of pyochelin-based conjugates.  
  
II.c. Fe(III) Detection Based on Lanthanide Displacement 
 Several displacement approaches for metal-ion detection have been reported and afford 
either a turn-on or turn-off fluorescence response to the metal ion of interest. Frequently, a 
metal ion that shares the same coordination site as the analyte and substantially quenches 
background emission from the receptor is employed. Displacement of this metal ion by the 
analyte results in fluorescence enhancement that is not achieved by using the receptor alone. 
This particular strategy has been utilized for turn-on Hg(II) sensing by Cu(II) displacement from 
a naphthlene-derivatized dihydrazone ligand,113  and for improving the dynamic range of the 
turn-on Zn(II) sensor Zinpyr-1 (ZP1) by substituting the Mn2:ZP1 complex for apo ZP1 as the 
Zn(II) probe.114 A complementary displacement tactic requires a lanthanide ion, the 
luminescence of which provides an indirect spectroscopic probe of the metal ion of interest 
following displacement of the antenna115 or the lanthanide ion itself. The latter strategy was 
recently employed for turn-off Fe(III) detection using terbium-bound N-methylanthranyl 
desferrioxamine B (19 and 20, Figure 7).89  
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Lanthanide ions coordinate to hydroxamate, catecholate, and salicylamide ligands, and 
siderophores have been proposed to mediate actinide mobility in contaminated subsurface 
environments.116,117 DFO B, 5, prevents Eu(III) absorption by goethite (α-FeOOH) and boehmite 
(γ-AlOOH), at least under laboratory conditions.118 The possibility of employing lanthanide 
complexes of N-methylanthranyl DFO B for Fe(III) detection was likely inspired, at least in part, 
from such prior studies. It was hypothesized that the N-methylanthranyl moiety would serve as 
the antenna and thereby transfer energy to the coordinated Ln(III) ion, providing luminescence. 
Following excitation of 19 at 340 nm, Tb(III) emission was observed in organic solvents such as 
ethyl acetate and acetonitrile. Addition of Fe(III) to a solution of 19 in ethyl acetate resulted in 
luminescence quenching, attributed to displacement of Tb(III) from the chelate and formation of 
21. A detection limit for Fe(III) was not provided for this siderophore-based detector, and the 
Tb(III) emission was quenched in protic solvents, including methanol and methanol/water 
mixtures, which limits its utility. A β-diketonate derivative of Tb:MA-DFB, 20, was next prepared 
by using hexafluoroacetylacetone (Hfac) as a blocking ligand to prevent water molecules from 
binding to the Tb(III) center. This β-diketonate complex exhibited Tb(III) emission in water, 
which was quenched following addition of Fe(III). A detection of 5 nM in water was reported; 
however, compound 20 was not tested in more complex or real-world samples. From the 
standpoint of design, the choice of Hfac as a blocking ligand over other β-diketones known to 
enhance Tb(III) luminescence is unclear, and systematic variation of the β-diketone may prove 
to be worthwhile for tuning the luminescence properties of the Tb(III) complex.119 Further studies 
will reveal whether such siderophore-based, Fe(III)-induced lanthanide displacement 
approaches are applicable to other siderophore scaffolds and have practical utility.  
 
III. Strategies for Pathogen Detection   
 In this section, we present four recent strategies for or applicable to the detection of 
microbial pathogens that require siderophores.54-56,120 These methods rely on siderophore 
immobilization and take advantage of the high-affinity association of siderophores to bacterial 
cell-surface receptors. Following iron coordination, ferric siderophores are recognized and 
sequestered by dedicated uptake machinery expressed on the cell membrane (Section I), which 
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provides a route for cytoplasmic entry. A number of siderophore receptors have been 
characterized structurally and biochemically with prominent examples including FepA121 
(enterobactin receptor) and FhuA122 (ferrichrome receptor) of E. coli, and FpvA123 (pyoverdine 
receptor) of Pseudomonas aeruginosa among others. These receptors exhibit specificity for one 
or several siderophores and bind these small molecules with dissociation constants in the 
nanomolar range. This specificity, in addition to the high-affinity binding capacity of the 
siderophore receptors, is attractive for developing species-specific bacterial identification and 
capture technologies. Moreover, from the perspective of pathogen detection, targeting 
siderophore receptors is worthwhile because the expression of functional siderophore uptake 
pumps is essential for proliferation and virulence in the iron-limiting environment of the 
vertebrate host. The likelihood of pathogens mutating these receptors is low.   
 A recent proof-of-concept example of siderophore-based pathogen detection involved 
polydimethylsiloxane (PDMS) stamping and immobilization of pyoverdine onto gold-plated glass 
chips for the capture of the opportunistic human pathogen Pseudomonas aeruginosa (Figure 
8).54 FpvA is the pyoverdine receptor expressed by P. aeruginosa and it has a Kd value of ca. 
0.5 nM for its iron-bound ligand.124,125 Pyoverdine was complexed with gallium and coupled to 
bovine serum albumin (BSA) by using carbodiimide chemistry. Subsequently, a PDMS stamp 
housing a pattern of repeating parallel ridges was treated with pyoverdine-BSA and employed to 
imprint a parallel pattern of pyoverdine-BSA onto gold-plate glass chips. In the first set of 
experiments, the chips were treated with solutions of DiO-labeled P. aeruginosa and the 
resulting emission pattern was visualized by using fluorescence microscopy. DiO, 3,3’-
dioctadecyloxacarbocyanine perchlorate, is a commercially-available fluorescent dye that binds 
to cell membranes. These experiments revealed a parallel pattern of DiO emission, with 
emission corresponding to the pyoverdine-functionalized regions of the chip. This pattern 
indicated that P. aeruginosa bound to the chip only where pyoverdine was attached. Because 
pre-loading the bacteria sample with a fluorophore is impractical for achieving rapid pathogen 
detection in real-world samples, the DiO-labeling step was ultimately circumvented by using 
light scattering, followed by Forrier transform analysis, to visualize the siderophore-captured 
bacteria. Using this technique, 104 cells/mL were routinely detected. In some instances, P. 
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aeruginosa from cultures at 102 cells/mL was observed. Only fifteen minutes were required for 
maximum P. aeruginosa binding, making this approach significantly more rapid compared to 
established methods for pathogen detection such as PCR-based screens.  
To probe the selectivity of the pyoverdine-modified chips for pyoverdine-producing 
organisms, the chips were treated with E. coli or Yersinia enterocolitica, species that neither 
express FpvA nor utilize pyoverdine for iron acquisition. Only negligible patterning was 
observed, supporting a requirement of a pyoverdine receptor for chip-based detection. It should 
be noted that the effect of metal-ion coordination by pyoverdine on the detection limit was not 
addressed in this study. It is unclear whether the pyoverdine stamped onto the gold chips is 
gallium-bound, iron-coordinated (resulting from iron-induced displacement of gallium), metal-
free or a mixture of these species. Although iron-free and gallium-bound pyoverdine bind to 
FpvA,124,126 the speciation may influence the detection limit for this system or for similar chips 
that utilize different siderophores. 
 Following this proof-of-concept report, the siderophore-modified chip methodology was 
extended to the detection of Yersinia enterocolitica.55 This Gram-negative human pathogen 
causes gastroenteritis and employs its xenosiderophore DFO (5, Figure 1) for iron acquisition. 
The receptor FoxA is responsible for ferrioxamine uptake by Y. enterocolitica,127,128 and 
utilization of this siderophore is associated with virulence and systemic infection in patients 
receiving chelation therapy for iron overload.129 A ferrioxamine-BSA conjugate was therefore 
prepared by using carbodiimide chemistry, and a PDMS stamp was treated with ferrioxamine-
BSA and used to pattern a gold-plated glass surface. The chips were subsequently incubated 
with 108 CFU/mL of Y. enterocolitica, which grown under iron-deficient conditions, and analysis 
of the chips revealed a light-scattering pattern attributed to pathogen capture. This pattern was 
not observed for chips treated with unmodified BSA or when the cultures of Y. enterocolitica 
were pretreated with desferrioxamine to saturate FoxA. LIVE/DEAD staining indicated that 
>95% of chip-bound bacteria were alive, and incubation of the chips with dead Y. enterocolitica 
resulted in no patterning. As observed for the pyoverdine-modified chips, signal saturation was 
observed following a ca. fifteen-minute incubation (108 cells/mL). Optimized chips, bearing a 20-
30% weight ratio of siderophore/BSA, afforded a detection limit of 103 CFU/mL observable by 
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the eye. The chips retained Yersinia capture ability after one year of storage. To evaluate the 
selectivity of the chips for ferrioxamine-utilizing microbes, the chips were treated with 
Staphylococcus aureus, Mycobacterium smegmatis, Pseudomonas aeruginosa, and Vibrio 
cholerae. Negligible to no pathogen capture was observed for cultures of S. aureus, M. 
smegmatis, and P. aeruginosa whereas V. cholerae was bound by the chips. An experiment 
testing chip performance with a mixed species sample was not reported. Nevertheless, these 
results point to a need for multiplexing and incorporating orthogonal siderophores on a given 
chip for rapid species-specific identification in mixed bacterial samples.  
 Siderophore-modified CdSe/ZnS quantum dots (QDs) were employed to capture 
Pseudomonas fluorescens previously isolated from the Dong-Hu Lake in China.56 P. fluorescens 
is typically found in soils and waters, and this bacterium produces the fluorescent siderophores 
pyoverdine and pyochelin amongst others. This species expresses the ferrichrome receptor.130 
P. fluorescens is a fish pathogen,131 and occasionally causes disease in humans with 
compromised immune systems.132,133 In this work, QDs were coated with polyethyleneglyco-
phosphoethanolamine (PEG-PD-QD) and ferrichrome was coupled to the terminal amino groups 
of PEG-PD-QD by using carbodiimide-based coupling chemistry. Incubation of the ferrichrome-
QDs with cultures of P. fluorescens resulted in clustering and sedimentation observable by 
fluorescence microscopy and UV-visible spectroscopy. The clustering phenomenon was not 
observed when the ferrichrome-QDs were incubated with Bacillus subtilis or with P. fluorescens 
cultures that were pre-incubated with ferrichrome.  
 The last proof-of-concept approach employs an immobilized siderophore designed to 
separate siderophore-binding proteins from cell extracts and is applicable to pathogen detection 
(Figure 9). Motivated to provide a simple and direct method for the discovery of siderophore-
binding proteins in cell extracts, a biotinylated derivative of petrobactin (22, B-petrobactin), a 
siderophore produced by marine bacteria134 and the human pathogens Bacillus cereus and 
Bacillus anthracis,135 was synthesized.120 The ferric complex of B-petrobactin was incubated 
with streptavidin-agarose beads, which were used to prepare a petrobactin-affinity column.  
Following pre-treatment of the column with BSA to reduce non-specific binding.  B. subtilis cell 
lysates were loaded onto the column and eluted with guanidinium chloride solution, and SDS-
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PAGE analysis of eluted fractions revealed that only one protein was repeatedly retained on the 
column. Trypsin digest and mass spectrometry identified this protein as YclQ, an ABC 
transporter binding protein and member of the yclNOPQ gene cluster. Prior work established 
that YclQ is the petrobactin-binding protein utilized by B. subtilis and that it coordinates apo and 
ferric petrobactin with Kd values of 32 and 142 nM, respectively (determined by fluorometric 
titration).136 Indeed, the B. subtilis mutant ΔyclQ did not exhibit growth recovery following 
supplementation of nutrient-depleted growth medium with petrobactin whereas growth recovery 
was observed for the control strain. In agreement with the B-petrobactin pull-down assay, these 
data indicate that YclQ is the only petrobactin-binding protein expressed on the B. subtilis cell 
surface.  
 Although this approach was intended for the discovery of siderophore-binding proteins, 
its applicability to pathogen capture is clear and warrants careful consideration. Incubating 
bacterial samples with biotinylated siderophores and resin or magnetic beads bearing 
streptavidin affords a means to separate the bound and unbound cells. Moreover, the 
biotin/streptavidin interaction may be employed in other immobilization strategies. A biotinylated 
ferrichrome, prepared by chemical synthesis137 and a biotinylated salmochelin, prepared by 
chemoenzymatic synthesis138 have been reported in the chemical literature. Synthetic routes to 
other biotinylated siderophores, and biotin attachment strategies that do not compromise iron 
coordination or interaction with the target receptor, are required for this approach to be broadly 
applicable. 
     
IV. Summary and Perspectives 
 This minireview summarizes advances in siderophore-based detection of iron and 
microbial pathogens reported through mid-2012. Building upon decades of fundamental studies 
in siderophore coordination chemistry, total synthesis and biology, some highlights of the past 
few years include reports of siderophore-based turn-on Fe(III) sensors and pathogen capture 
strategies. These proof-of-concept studies warrant further elaboration. Moreover, additional 
directions in both fundamental research and technology development with broad impact (i.e. 
environmental monitoring, therapeutics, diagnostics) exist. Along these lines, expanding the 
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toolbox of available siderophore scaffolds is an important step for advancing the field. Of ca. 
500 siderophores isolated to date, only a handful have been evaluated in applications-based 
work. DFO, pyoverdine family members, and synthetic siderophore mimics are commonly 
employed because they are commercially available (i.e. DFO) or easily obtainable (i.e. 
pyoverdines), and afford relatively facile chemical modification. Limitations in siderophore 
availability may result from difficulties in cultivating the producer organism and/or isolating 
adequate quantities of the molecule in high purity from cultures. In addition, site-specific 
chemical modification of native siderophore platforms that house multiple functional groups is 
oftentimes challenging. Organic synthesis affords the means to circumvent these issues, and 
the total syntheses of many siderophores have been achieved. The synthetic routes to 
functionalized mycobactin,48 petrobactin,120 and pychelin88 scaffolds reported in 2010-2011 
provide opportunities for further elaboration. Chemoenzymatic and biosynthetic production of 
novel siderophores and siderophore conjugates are additional avenues worthy of exploration. 
Indeed, an artificial pathway to 3,4-dihydroxybenzoic acid was recently utilized to produce a 
novel catechol-derived aminocoumarin antibiotic in Streptomycetes coelicolor M512.139  
 From the standpoint of Fe(III) detection, additional photophysical characterization of 
fluorescent siderophores and fluorophore-siderophore conjugates is warranted. Standard 
characterization (i.e. quantum yield values and extinction coefficients for the apo and metal-
bound species) is often lacking. In some instances, these values were determined in prior work 
and under conditions irrelevant to the sensing application. These data provide valuable 
quantitative information useful for making comparisons between molecules, and are generally 
required by other sensing fields. Lastly, more detailed mechanistic studies, especially for 
molecules that provide fluorescence enhancement with Fe(III) coordination, will afford valuable 
insights of broad relevance to the metal-ion sensing field and aid future sensor design.  
 Whether the proof-of-concept methods for pathogen capture and siderophore-protein 
discovery described above are applicable to pathogen detection in more complex biological and 
clinical samples remains to be evaluated. Testing in real-world samples is an important first step 
in this regard, and achieving the required sensitivity and selectivity will likely require optimization 
and new design strategies that include multiplexing. In closing, we aim for this minireview to 
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summarize highlights spanning approximately two decades of siderophore-based detection 
research, provide a helpful resource for the community, and catalyze new frontiers in 
siderophore-based research. We look forward to the outcomes of such future endeavors. 
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Table 1. Properties of select siderophores produced by bacteria and fungi.  




1 Pyoverdine Pseudomonas spp. 30.8 27 yes 100 









3 Azotobactin δ Azotobacter vinelandii 28.1 27.8 yes 74 
4 Yersiniabactin Yersinia enterocolitica, Yersinia 
pestis 
36.6 n.d. yes 140 
5 Desferrioxamine B Nocardia spp., Streptomyces spp. 30.6 26.6 no 141 
6 Ferrichrome Aspergillus spp., Penicillium spp., 
Ustilago spp. 
29.1 25.2 no 142, 
143 
7 Enterobactin Klebisella spp., Enterobacter spp., 
Erwinia spp. 
49 35.5 no 144 
8 Parabactin Paracoccus denitrificans ~48 n.d.f yes 101 
9 Petrobactin Marinobacter hydrocarbonoclasticus, 
Bacillus cereus, Bacillus anthracis 
43 23.1 no 145 
10 Mycobactin S Mycobacterium smegmatis 26.6 n.d.f no 146 
11 Staphyloferrin B Staphylococcus hyicus n.d.f n.d.f no  
a Select examples of producing organisms. b Kf is the apparent forming constant of FeIII and the fully 
deprotonated ligand. c When [FeIII]total = 10-6 M, [L]total = 10-5 M, at pH 7.4. d The references specify the 
source of the stability constant. e The first value was determined in methanol due to the low solubility of 














	   32 
Figure Captions 
 
Figure 1.  Examples of siderophores produced by Gram-negative bacteria (1-5, 7-10), Gram-
positive bacteria (11) and fungi (6). The iron-coordinating moieties are highlighted in red. 
Multiple structural variants of some siderophores exist (i.e. pyoverdines, azotobactins, 
desferrioxamines, mycobactins, etc.). In such cases, one example is provided and referred to 
throughout the text unless noted otherwise. 
 
Figure 2. Structures of ferrioxamine B (ref. 20), [Fe(ferrichrome)] (ref. 21), [Fe(yersiniabactin)]- 
(ref. 22) and [V(enterobactin)]2- (ref. 23) determined by X-ray crystallographic analysis. The 
oxygen atoms are depicted in red, the nitrogen atoms in blue, the sulfur atoms in yellow, and the 
carbon atoms in grey. The metal ions are labeled in green and the hydrogen atoms are omitted 
for clarity. 
 
Figure 3. Immobilization of ferrioxamine B onto glycidoxy-grafted silica gel (ref. 79).   
 
Figure 4. Structures of NBD- and fluorescein-containing fluorophore-DFO conjugates 12-14. 
The donor atoms are depicted in red and the fluorophores are labeled in blue. 
 
Figure 5. Structures of cypate-DFO conjugates 15-16 designed for cancer imaging studies. The 
donor atoms are depicted in red and the cypate fluorophores are labeled in blue. 
 
Figure 6. Structure of pyochelin-NBD conjugates 17-18 that give fluorescence turn-on with 
Fe(III) coordination in aqueous solution. The donor atoms are depicted in red and the NBD 
fluorophores are labeled blue. 
 
Figure 7. Iron detection based on lanthanide displacement. Molecules 19 and 20 exhibit terbium 
luminescence, which is quenched following Fe(III)-mediated Tb(III) displacement. The N-
methylanthranyl moiety is depicted in blue.  
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Figure 8. Pathogen detection using siderophore-immobilization on glass chips (refs. 54 and 55). 
(A) Application of the siderophore-BSA conjugate to a PDMS stamp. (B) Immobilization of 
siderophore-BSA onto a gold-plated glass chip. (C) Exposure of the chip to a bacterial culture. 
(D) Imaging of bacterial capture. 
 
Figure 9. (A) Isolation of siderophore-binding proteins by using biotin-siderophore conjugates 
(ref. 120). (B) Structure of biotinylated petrobactin 22. The donor atoms are depicted in red and 
the biotin moiety is labeled in blue. 
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Figure 8. Zheng & Nolan (one column) 
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This minireview summarizes siderophore-based methods for the fluorescence detection of 
Fe(III) and capture of bacterial pathogens.  
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